Nikolay A. Belyakov

Nikolay A. Belyakov

Auto-generated profile, based on publicly available information

Nikolay A. Belyakov

St. Petersburg Pasteur Institute

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
OLO. N. Leonova
O. N. Leonova
YSYe. V. Stepanova
Ye. V. Stepanova
NBN. A. Belyakov
N. A. Belyakov
Повышение уровня смертности среди пациентов с ВИЧ-инфекцией оказывает существенное негативное влияние на социально-экономическую и демографическую ситуацию в Российской Федерации. Цель исследования. Причины смерти ВИЧ-инфицированных больных с коморбидными состояниями. Материалы и методы. Проведен ретроспективный анализ 265 историй болезни умерших пациентов, поступивших в стационар СПБ ГБУЗ «Центр по профилактике и борьбе со СПИД и инфекционными заболеваниями» за период с 2010 по 2014 год. Диагноз сопутствующей патологии устанавливался по результатам клинических, лабораторных, инструментальных исследований и по анамнестическим данным. Результаты. Охарактеризованы некоторые медико-социальные параметры умерших больных. По результатам анализа, из 265 умерших пациентов с ВИЧ-инфекцией у 16% ВИЧ выявлен впервые. От оппортунистических заболеваний умерли 203 (76,6%) пациента, сопутствующая патология стала основной причиной смерти у 62 (23,4%) больных. Тяжесть состояния умерших пациентов заключалась в позднем поступлении в стационар нашего центра, в наличии микст-инфекции, тяжелой сопутствующей патологии. Из общего количества больных антиретровирусная терапия была назначена 193 пациентам, с длительностью приема от 1 месяца до 3-х лет. Состояние пациентов прогрессивно ухудшалось на фоне прерванной антиретровирусной терапии или не приверженного ее приема, отсутствия профилактических курсов оппортунистических инфекций, лечения соматической патологии. Заключение. Ведущей причиной летального исхода у больных на продвинутых стадиях ВИЧ-инфекции было наличие тяжелых коморбидных вариантов течения ВИЧ-инфекции: ВИЧ и коинфекция хронических вирусных гепатитов, туберкулез, ВИЧ и злокачественные опухоли, ВИЧ-ассоциированные неврологические заболевания, употребление психоактивных веществ на фоне прогрессирования ВИЧ-инфекции.

16 May 2022 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
NBN. A. Belyakov
N. A. Belyakov
EBE. V. Boeva
E. V. Boeva
OSO. E. Simakina
O. E. Simakina
YSYu. S. Svetlichnaya
Yu. S. Svetlichnaya
SOS. V. Ogurtsova
S. V. Ogurtsova
ISI. O. Stoma
I. O. Stoma
The purpose statement is to assess the course of the COVID-19 pandemic and its impact on the epidemics of HIV infection, viral hepatitis C (HCV), tuberculosis, influenza, and acute respiratory infections in the North-Western Federal District (NWFD) of the Russian Federation during two years of spreading COVID-19 from the standpoint of the possible formation of syndemia or interference between pathogens.Materials and methods. Data collection on HIV infection and HCV was carried out by Pasteur Research Institute of Epidemiology and Microbiology at St. Petersburg Medical Information and Analytical Center using data from federal state statistical observation forms and our own research materials. The indicators of excess mortality from all causes for 2020 in the Northwestern Federal District (NWFD) and in the Russian Federation were analyzed according to the data of the Federal State Statistics Service (ROSSTAT). The results of epidemiological surveillance of HIV infection, viral hepatitis C (HCV), and tuberculosis in the Russian Federation and in the NWED in 2020 and 2021 in comparison with previous years are summarized. Studies of influenza and SARS were carried out by Smorodintsev Research Institute of Influenza and Gamaleya National Research Center for Epidemiology and Microbiology in cooperation with regional support bases. PCR detection of ARVI pathogens was carried out.Results and discussion. An analysis of epidemic indicators across the territories of the Northwestern Federal District of the Russian Federation made it possible to identify the following features: heterogeneity of the incidence of COVID-19 in the population in terms of time and intensity; the prevalence of morbidity in the metropolis (St. Petersburg) and industrial northern regions (the republics of Karelia and Komi). In a comparative aspect, the NWFD belongs to regions with high morbidity and mortality in the Russian Federation. St. Petersburg (378 deaths per 100,000 people in 2021) ranks second after Moscow. In turn, the Vologda, Murmansk, and Arkhangelsk regions, as well as the Komi Republic are among the top ten of the most affected subjects of the Russian Federation in the country. In terms of mortality, St. Petersburg was significantly ahead of all other subjects of the Russian Federation and the national average, which had several probable reasons. The first and second years of the pandemic did not reveal significant changes in epidemic rates of morbidity and mortality from other socially significant infections — HIV, HCV, and tuberculosis at the population level characteristic interference of viruses, where SARS-CoV-2 took the place of interfering, and influenza and SARS pretending or interfering pathogens. It took several months until the beginning of winter 2020 to crowd out seasonal respiratory infections by SARS-CoV-2. Then SARS-CoV-2 tightly captured the epidemic space, leaving no room for traditional respiratory infections, which accounted for less than 5% in early 2022.Conclusion. The COVID-19 epidemic had pronounced developmental features with higher morbidity and mortality in the metropolis and other industrial centers. The pandemic did not significantly affect the patterns of the epidemic course of HIV, HCV, and tuberculosis, which rejected the presence of a syndemic between these pathogens. Interference with respiratory infections — influenza and SARS — was revealed with a clear predominance of SARS-CoV-2.

28 January 2022 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
NBN. A. Belyakov
N. A. Belyakov
TTT. N. Trofimova
T. N. Trofimova
VRVadim Rassokhin
Vadim Rassokhin
MRM. G. Rybakova
M. G. Rybakova
BVB. B. Vasiliev
B. B. Vasiliev
COVID-19, having not completed its epidemic development, gradually passes into the stage of prolonged diseases, which at the clinical level is designated as «postcovid syndrome». The symptomatology of these negative phenomena is quite diverse, covers the dysfunction of many organs and systems, and deserves the formulation of polymorphism of secondary and delayed complications. They are based on the consequences of the transferred acute phase of inflammation, systemic prolonged metabolic and structural disorders, including the studied genetic disorders. Possible causes of polymorphism of disorders and their manifestations in the postcovid period are considered.

1 January 2017 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
NBN. A. Belyakov
N. A. Belyakov
VRVadim Rassokhin
Vadim Rassokhin
AБArray С. Бобрешова
Array С. Бобрешова
AБArray А. Беляков
Array А. Беляков
ПРОТИВОДЕЙСТВИЕ ВИЧ-ИНФЕКЦИИ И РОСТ ЗАБОЛЕВАЕМОСТИ В РОССИИ

Verified
Journal Article
Open access
PDF file
Zoia R. KorobovaZoia R. Korobova
Zoia R. Korobova
NANatalia Arsentieva
Natalia Arsentieva
NLNatalia E. Liubimova
Natalia E. Liubimova
OBOleg K. Batsunov
Oleg K. Batsunov
ABAnastasiya Butenko
Anastasiya Butenko
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Background: Long COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection. This study aims to evaluate immune system markers, including antigen-specific antibodies, B cell subsets, and Th2-related cytokines, in individuals with long COVID and to investigate their potential impact on the development of this condition. Methods: We analyzed blood plasma from 63 individuals diagnosed with long COVID based on clinical presentation and 47 healthy individuals with COVID-19 history but no clinical symptoms. Antigen-specific IgG antibodies were measured using commercial ELISA kits. Lymphocyte subpopulations were assessed via flow cytometry and a gating strategy based on CD27 and CD38. Th2 cytokines (IL-4, IL-5, IL-13) were quantified using the xMAP multiplex assay. Results: We noted no significant differences in IgG levels between groups. Notably, individuals with long COVID demonstrated a higher percentage of naive mature B cells (CD27−CD38+), while transitional (CD27−CD38+++) and double-negative (DN, CD27−CD38-) cells were significantly reduced. Elevated levels of IL-5 and IL-13 were observed in long COVID patients. Classification analysis revealed that the percentage of transitional B cells (CD27−CD38+++) was a strong predictor of long COVID. Conclusions: Our findings highlight alterations in B cell dynamics among individuals with long COVID, which may contribute to autoimmune processes.

Verified
Journal Article
Open access
PDF file
Zoia R. KorobovaZoia R. Korobova
Zoia R. Korobova
NANatalia Arsentieva
Natalia Arsentieva
ABAnastasiya Butenko
Anastasiya Butenko
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
ARArtem Rubinstein
Artem Rubinstein
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Despite targeting mainly the respiratory tract, SARS-CoV-2 disrupts T cell homeostasis in ways that may explain both acute lethality and long-term immunological consequences. In this study, we aimed to evaluate the T-cell-mediated chain of immunity and formation of TCR via TREC assessment in COVID-19 and long COVID (LC). For this study, we collected 231 blood samples taken from patients with acute COVID-19 (n = 71), convalescents (n = 51), people diagnosed with LC (n = 63), and healthy volunteers (n = 46). With flow cytometry, we assessed levels of CD4+ and CD8+ minor T cell subpopulations (i.e., naïve, central and effector memory cells (CM and EM), Th1, Th2, Th17, Tfh, Tc1, Tc2, Tc17, Tc17.1, and subpopulations of effector cells (pE1, pE2, effector cells)). Additionally, we measured TREC levels. We found distinct changes in immune cell distribution—whilst distribution of major subpopulations of T cells was similar between cohorts, we noted that COVID-19 was associated with a decrease in naïve Th and CTLs, an increase in Th2/Tc2 lymphocyte polarization, an increase in CM cells, and a decrease in effector memory cells 1,3, and TEMRA cells. LC was associated with naïve CTL increase, polarization towards Th2 population, and a decrease in Tc1, Tc2, Em2, 3, 4 cells. We also noted TREC correlating with naïve cells subpopulations. Our findings suggest ongoing immune dysregulation, possibly driven by persistent antigen exposure or tissue migration of effector cells. The positive correlation between TREC levels and naïve T cells in LC patients points to residual thymic activity. The observed Th2/Th17 bias supports the hypothesis that LC involves autoimmune mechanisms, potentially driven by molecular mimicry or loss of immune tolerance.